Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marguerita Lightfoot is active.

Publication


Featured researches published by Marguerita Lightfoot.


Aids Patient Care and Stds | 2003

Theory-Guided, Empirically Supported Avenues for Intervention on HIV Medication Nonadherence: Findings from the Healthy Living Project

Mallory O. Johnson; Sheryl L. Catz; Robert H. Remien; Mary Jane Rotheram-Borus; Stephen F. Morin; Edwin D. Charlebois; Cheryl Gore-Felton; Rise B. Goldsten; Hannah Wolfe; Marguerita Lightfoot; Margaret A. Chesney

OBJECTIVES Adherence to antiretroviral therapy (ART) remains a challenge in efforts to maximize HIV treatment benefits. Previous studies of antiretroviral adherence are limited by low statistical power, homogeneous samples, and biased assessment methods. Based on Social Action Theory and using a large, diverse sample of men and women living with HIV, the objectives of the current study are to clarify correlates of nonadherence to ART and to provide theory-guided, empirically supported direction for intervening on ART nonadherence. DESIGN Cross-sectional interview study utilizing a computerized interview. SETTING Recruited from clinics, agencies, and via media ads in four U.S. cities from June 2000 to January 2002. PARTICIPANTS Two thousand seven hundred and sixty-five HIV-positive adults taking ART. MAIN OUTCOME MEASURE Computer-assessed self-reported antiretroviral adherence. RESULTS Thirty-two percent reported less than 90% adherence to ART in the prior 3 days. A number of factors were related to nonadherence in univariate analysis. Multivariate analyses identified that being African American, being in a primary relationship, and a history of injection drug use or homelessness in the past year were associated with greater likelihood of nonadherence. Furthermore, adherence self-efficacy, and being able to manage side effects and fit medications into daily routines were protective against nonadherence. Being tired of taking medications was associated with poorer adherence whereas a belief that nonadherence can make the virus stronger was associated with better adherence. CONCLUSIONS Results support the need for multifocused interventions to improve medication adherence that address logistical barriers, substance use, attitudes and expectancies, as well as skills building and self-efficacy enhancement. Further exploration of issues related to adherence for African Americans and men in primary relationships is warranted.


Journal of Acquired Immune Deficiency Syndromes | 2004

HIV transmission risk behavior among men and women living with HIV in 4 cities in the United States.

Lance S. Weinhardt; Jeffrey A. Kelly; Michael J. Brondino; Mary Jane Rotheram-Borus; Sheri B. Kirshenbaum; Margaret A. Chesney; Robert H. Remien; Stephen F. Morin; Marguerita Lightfoot; Anke A. Ehrhardt; Mallory O. Johnson; Sheryl L. Catz; Steven D. Pinkerton; Eric G. Benotsch; Daniel Hong; Cheryl Gore-Felton

Summary:Determining rates of HIV transmission risk behavior among HIV-positive individuals is a public health priority, especially as infected persons live longer because of improved medical treatments. Few studies have assessed the potential for transmission to the partners of HIV-positive persons who engage in high-risk activities. A total of 3723 HIV-infected persons (1918 men who have sex with men [MSM], 978 women, and 827 heterosexual men) were interviewed in clinics and community-based agencies in Los Angeles, Milwaukee, New York City, and San Francisco from June 2000 to January 2002 regarding sexual and drug use behaviors that confer risk for transmitting HIV. Less than one quarter of women and heterosexual men had 2 or more sexual partners, whereas 59% of MSM reported having multiple partners. Most unprotected vaginal and anal sexual activity took place in the context of relationships with other HIV-positive individuals. Approximately 19% of women, 15.6% of MSM, and 13.1% of heterosexual men engaged in unprotected vaginal or anal intercourse with partners who were HIV-negative or whose serostatus was unknown. The majority of sexually active participants disclosed their serostatus to all partners with whom they engaged in unprotected intercourse. An estimated 30.4 new infections (79.7% as a result of sexual interactions with MSM) would be expected among the sex partners of study participants during the 3-month reporting period. Eighteen percent of 304 participants who injected drugs in the past 3 months reported lending their used injection equipment to others. In addition to the more traditional approaches of HIV test counseling and of focusing on persons not infected, intensive prevention programs for persons with HIV infection are needed to stem the future spread of the virus.


Journal of Acquired Immune Deficiency Syndromes | 2004

Prevention for Substance-Using HIV-Positive Young People Telephone and In-Person Delivery

Mary Jane Rotheram-Borus; Dallas Swendeman; W. Scott Comulada; Robert E. Weiss; Martha E Lee; Marguerita Lightfoot

SummaryHIV risky behaviors and health practices were examined among young people living with HIV (YPLH) in Los Angeles, San Francisco, and New York over 15 months in response to receiving a preventive intervention. YPLH aged 16 to 29 years (n = 175; 26% black and 42% Latino; 69% gay men) were randomly assigned to a 3-module intervention totaling 18 sessions delivered by telephone, in person, or a delayed-intervention condition. Intention-to-treat analyses found that the in-person intervention resulted in a significantly higher proportion of sexual acts protected by condoms overall and with HIV-seronegative partners. Pre- and postanalyses of YPLH in the delayed-intervention condition alone found that YPLH tended to have fewer sexual partners, used fewer drugs, reported less emotional distress, and decreased their use of antiretroviral therapies. Prevention programs can be delivered in alternative formats while retaining efficacy. When YPLH are using hard drugs, drug treatment may be needed before delivery of preventive interventions.


Journal of Acquired Immune Deficiency Syndromes | 2007

Effects of a behavioral intervention to reduce risk of transmission among people living with HIV: The Healthy Living Project randomized controlled study

Stephen F. Morin; Margaret A. Chesney; Anke A. Ehrhardt; Jeffrey A. Kelly; Willo Pequegnat; Mary Jane Rotheram-Borus; Abdelmonem A. Afifi; Eric G. Benotsch; Michael J. Brondino; Sheryl L. Catz; Edwin D. Charlebois; William G. Cumberland; Don C. DesJarlais; Naihua Duan; Theresa M. Exner; Risë B. Goldstein; Cheryl Gore-Felton; A. Elizabeth Hirky; Mallory O. Johnson; Robert M. Kertzner; Sheri B. Kirshenbaum; Lauren Kittel; Robert Klitzman; Martha B. Lee; Bruce Levin; Marguerita Lightfoot; Steven D. Pinkerton; Robert H. Remien; Fen Rhodes; Juwon Song

Context:The US Centers for Disease Control and Prevention (CDC) strongly recommend comprehensive risk counceling and services for people living with HIV (PLH); yet, there are no evidence-based counseling protocols. Objective:To examine the effect of a 15-session, individually delivered, cognitive behavioral intervention on a diverse sample of PLH at risk of transmitting to others. Design:This was a multisite, 2-group, randomized, controlled trial. Participants:Nine hundred thirty-six HIV-infected participants considered to be at risk of transmitting HIV of 3818 persons screened were randomized into the trial. Participants were recruited in Los Angeles, Milwaukee, New York, and San Francisco. Intervention:Fifteen 90-minute individually delivered intervention sessions were divided into 3 modules: stress, coping, and adjustment; safer behaviors; and health behaviors. The control group received no intervention until the trial was completed. Both groups completed follow-up assessments at 5, 10, 15, 20, and 25 months after randomization. Main Outcome Measure:Transmission risk, as measured by the number of unprotected sexual risk acts with persons of HIV-negative or unknown status, was the main outcome measure. Results:Overall, a significance difference in mean transmission risk acts was shown between the intervention and control arms over 5 to 25 months (χ2 = 16.0, degrees of freedom = 5; P = 0.007). The greatest reduction occurred at the 20-month follow-up, with a 36% reduction in the intervention group compared with the control group. Conclusion:Cognitive behavioral intervention programs can effectively reduce the potential of HIV transmission to others among PLH who report significant transmission risk behavior.


Aids Care-psychological and Socio-medical Aspects of Aids\/hiv | 2004

Intricacies and inter-relationships between HIV disclosure and HAART: A qualitative study

Robert Klitzman; Sheri B. Kirshenbaum; Brian Dodge; Robert H. Remien; Anke A. Ehrhardt; Mallory O. Johnson; Lauren Kittel; Shaira Daya; Stephen F. Morin; Jeffrey A. Kelly; Marguerita Lightfoot; Mary Jane Rotheram-Borus

This study aimed to understand whether and how highly active antiretroviral treatment (HAART) affects views and patterns of disclosure and how disclosure interacts with treatment decisions. One hundred and fifty-two HIV-positive adults (52 MSM, 56 women and 44 IDU men) from four US cities participated in two to three-hour, semi-structured interviews in 1998–99. Results indicate that HAART interacts with and shapes HIV disclosure issues in several ways. Medications may ‘out’ people living with HIV. Thus, in different settings (e.g. work, prisons, drug rehabs and public situations), some try to hide medications or modify dosing schedules, which can contribute to non-adherence, and affect sexual behaviours. Disclosure of HIV and/or HAART may also result in antagonism from others who hold negative attitudes and beliefs about HAART, potentially impeding adherence. Observable side effects of medications can also ‘out’ individuals. Conversely, medications may improve appearance, delaying or impeding disclosure. Some wait until they are on HAART and look ‘well’ before disclosing; some who look healthy as a result of medication deny being HIV-positive. Alternatively, HIV disclosure can lead to support that facilitates initiation of, and adherence to, treatment. HIV disclosure and adherence can shape one another in critical ways. Yet these interactions have been under-studied and need to be further examined. Interventions and studies concerning each of these domains have generally been separate, but need to be integrated, and the importance of relationships between these two areas needs to be recognized.


Journal of Acquired Immune Deficiency Syndromes | 2011

Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization.

Adam W. Carrico; Elise D. Riley; Mallory O. Johnson; Edwin D. Charlebois; Torsten B. Neilands; Robert H. Remien; Marguerita Lightfoot; Wayne T. Steward; Lance S. Weinhardt; Jeffrey A. Kelly; Mary Jane Rotheram-Borus; Stephen F. Morin; Margaret A. Chesney

Background:In the era of antiretroviral therapy (ART), depression and substance use predict hastened HIV disease progression, but the underlying biological or behavioral mechanisms that explain these effects are not fully understood. Methods:Using outcome data from 603 participants enrolled in a randomized controlled trial of a behavioral intervention, binary logistic and linear regression were employed to examine whether inconsistent patterns of ART utilization partially mediated the effects of depression and substance use on higher HIV viral load over a 25-month follow-up. Results:Elevated affective symptoms of depression independently predicted ART discontinuation [adjusted odds ratio = 1.39, 95% confidence interval (CI) = 1.08 to 1.78], and use of stimulants at least weekly independently predicted intermittent ART utilization (adjusted odds ratio = 2.62, 95% CI = 1.45 to 4.73). After controlling for the average self-reported percentage of ART doses taken and baseline T-helper (CD4+) count, elevated depressive symptoms predicted a 50% higher mean viral load, and weekly stimulant use predicted a 137% higher mean viral load. These effects became nonsignificant after accounting for inconsistent patterns of ART utilization, providing evidence of partial mediation. Conclusions:Inconsistent patterns of ART utilization may partially explain the effects of depression and stimulant use on hastened HIV disease progression.


Journal of Acquired Immune Deficiency Syndromes | 2005

Predicting HIV transmission risk among HIV-infected men who have sex with men: findings from the healthy living project.

Stephen F. Morin; Wayne T. Steward; Edwin D. Charlebois; Robert H. Remien; Steven D. Pinkerton; Mallory O. Johnson; Mary Jane Rotheram-Borus; Marguerita Lightfoot; Ris B Goldstein; Lauren Kittel; Farishta Samimy-Muzaffar; Lance S. Weinhardt; Jeffrey A. Kelly; Margaret A. Chesney

Objective:To examine the predictors of transmission risk among HIV-infected men who have sex with men (MSM) in 4 US cities. Method:Individual computer-assisted interviews assessing psychologic measures and sexual behavior with the 5 most recent male and female partners were conducted with a diverse sample of 1910 HIV-infected MSM recruited from community and clinic settings in San Francisco, New York, Los Angeles, and Milwaukee. Transmission-risk events were defined as unprotected vaginal or anal sex with a partner who was HIV negative or of unknown status. Results:A small but not insignificant proportion of MSM (12.7%) reported at least 1 transmission-risk event in the previous 3 months, with 57% of those events taking place with casual as opposed to steady partners. Multivariate predictors of transmission risk with casual partners were stimulant (eg, crystal methamphetamine) and other drug use, having low coping self-efficacy, and not having disclosed ones HIV serostatus to all partners. Stimulant use and failing to disclosing ones serostatus to all partners were associated with risk in primary relationships. Conclusions:Responding to HIV transmission risk in MSM requires different strategies for primary and casual partners.


AIDS | 2003

Four-year behavioral outcomes of an intervention for parents living with HIV and their adolescent children.

Mary Jane Rotheram-Borus; Martha B. Lee; Noelle R. Leonard; Ying Ying Lin; Laura H. Franzke; Elizabeth Turner; Marguerita Lightfoot; Marya Gwadz

Objective: The adjustment of parents living with HIV (PLH) and their adolescent children was examined over 4 years in response to an intervention. Outcomes at 2 years had been previously published. Methods: A randomized controlled trial was conducted, with a representative sample from New York City. Results: In the intervention condition, fewer adolescents became teenage parents, and conduct problems tended to be lower over 4 years than in the standard care condition. Fewer parents were drug dependent and tended to relapse into substance use or use passive coping styles compared with the standard care condition over 4 years. The time-trend analysis showed that the significant reductions in problem behaviors and emotional distress previously observed over 15–24 months in the intervention condition, then eroded over time and were non-significant at 48 months. Conclusions: Ongoing support and skills are needed to maintain intervention effects over longer periods.


American Journal of Public Health | 2007

Computerized HIV Preventive Intervention for Adolescents: Indications of Efficacy

Marguerita Lightfoot; W. Scott Comulada; Gabriel N. Stover

We tested the hypothesis that a computerized intervention would be as efficacious as an in-person, small-group intervention in reducing sexual risk behaviors. The sexual behavior of high-risk adolescents in 3 intervention conditions was examined: (1) computer based, (2) small groups, and (3) control. Adolescents in the computerized intervention were significantly less likely to engage in sexual activity and reported significantly fewer partners. For some youths, computers are a viable way to deliver prevention information and promote skill development.


Journal of Adolescent Health | 2012

The Intersection of Youth, Technology, and New Media with Sexual Health: Moving the Research Agenda Forward

Susannah Allison; José A. Bauermeister; Sheana Bull; Marguerita Lightfoot; Brian Mustanski; Ross Shegog; Deb Levine

Youth bear a significant proportion of the sexually transmitted infection (STI)/HIV burden in the United States, CDC, 2010. Available at: http://www.cdc.gov/std/stats09/default.htm, with rates of some STIs increasing among youth of color and young men who have sex with men. Technology use among youth also continues to increase. The ubiquitous nature of technology use among youth offers a multitude of opportunities to promote youth sexual health and to prevent disease transmission and unplanned pregnancies. To date, there have been a handful of peer-reviewed articles published regarding the feasibility, acceptability, and effectiveness of using new media and technology for sexual health promotion. Despite recent publications, there is still a real need for high-quality research to understand the impact of different forms of new media use on youth sexual health, as well as to determine the best ways to harness technology to promote safer sex behaviors, both for the short- and long-term. In March 2011, Internet Sexuality Information Services (ISIS), National Institute of Mental Health (NIMH), and the Ford Foundation convened a meeting of scientists and technology experts to discuss how to effectively conduct sexual health promotion research using new forms of technology. The meeting was structured to cover the following topic areas: (i) research-community partnerships, (ii) institutional review board and ethical issues, (iii) theoretical frameworks, (iv) intervention approaches, (v) recruitment methods, and (vi) assessing impact. Presentations included case studies of successful technology-based HIV/STI prevention interventions for youth, which led to broader discussions on how to conduct research in this area. This article summarizes the meeting proceedings, highlights key points, offers recommendations, and outlines future directions.

Collaboration


Dive into the Marguerita Lightfoot's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lance S. Weinhardt

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jeffrey A. Kelly

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge